title: Staphylococcal Scalded Skin Syndrome: A Case Review.
abstract: Staphylococcal scalded skin syndrome (SSSS) is a rare yet well-known exfoliative skin syndrome. It involves extensive desquamated areas caused by an exfoliative toxin from Staphylococcus aureus. The typical presentation of SSSS allows for early diagnosis and treatment of the disease. Knowing and understanding the prevalence, pathophysiology, risk factors, and diagnosis of SSSS will ensure that infants being treated and cared for by neonatal nurses and neonatal nurse practitioners will receive appropriate, comprehensive, and multidisciplinary care while in the NICU. The purpose of this case review is to inform neonatal nurses and practitioners of the current literature that focuses on the diagnosis and management of SSSS.
authors: Kourtney
authors: K
authors: Hennigan
authors: Cheryl
authors: C
authors: Riley
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D004643:Emollients / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D009020:Morphine / Q000008:administration & dosage*; D009254:Nafcillin / Q000008:administration & dosage*; D009779:Occlusive Dressings; D013206:Staphylococcal Scalded Skin Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D016896:Treatment Outcome
chemical_list: D000701:Analgesics, Opioid; D000900:Anti-Bacterial Agents; D004643:Emollients; D009254:Nafcillin; D009020:Morphine